Retina-Vitreous
2021 , Vol 30 , Num 1
Radiation Retinopathy; A Journey With Intravitreal Injections Through 12.5 Years of Treatment and Follow-Up
1MD, Ophthalmology Department of Dokuz Eylül University, Medicine School İzmir, Turkey2Prof., MD, Ophthalmology Department of Dokuz Eylül University, Medicine School İzmir, Turkey DOI : 10.37845/ret.vit.2021.30.13 The records of a patient who has been treated for radiation retinopathy following the administration of external radiotherapy for Graves ophthalmopathy was reviewed retrospectively.A total of 60 intravitreal injections were administered into the patient's right eye during a period of 12.5 years (triamcinolone acetonide, pegaptanib, bevacizumab, ranibizumab,aflibercept,dexamethazone implant) . Visual acuity of the right eye remained the same as baseline visual acuity of 0.2 with the Snellen chart during the follow up. Macular edema related to radiation retinopathy could not be fully controlled during the course of follow -up . Various agents were administered during the follow-up period due to persistent nature of the macular edema. The clinical course refl ects the relatively negative character of the disease and also proves that radiation maculopathy is a very resistant disease requiring almost continuous intravitreal therapy.. Keywords : Afl ibercept, Bevacizumab, Dexamethasone implant, Radiation retinopathy, Ranibizumab